Reference health
Coronavirus Particle Assembly: Primary Structure Requirements of the Membrane Protein
78/78 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 78 checked references that resolve
resolves10.1128/jvi.69.9.5816-5820.1995
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form
resolves10.1038/308751a0
Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus
resolves10.1007/978-1-4684-5823-7_11
Molecular Characterization of the 229E Strain of Human Coronavirus
resolves10.1128/jvi.66.12.7560-7564.1992
Alphavirus assembly and entry: role of the cytoplasmic tail of the E1 spike subunit
resolves10.1128/jvi.67.11.6762-6767.1993
Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions
resolves10.1006/viro.1996.0165
The Production of Recombinant Infectious DI-Particles of a Murine Coronavirus in the Absence of Helper Virus
resolves10.1002/j.1460-2075.1996.tb00964.x
Direct interaction between the envelope and matrix proteins of HIV‐1.
resolves10.1002/j.1460-2075.1989.tb08405.x
The GAG precursor of simian immunodeficiency virus assembles into virus‐like particles.
resolves10.1128/jvi.69.6.3441-3448.1995
The small envelope glycoprotein (GS) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer
resolves10.1128/jvi.66.11.6616-6625.1992
Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
resolves10.1128/jvi.69.4.2471-2479.1995
Mutations in the putative fusion peptide of Semliki Forest virus affect spike protein oligomerization and virus assembly
resolves10.1002/j.1460-2075.1994.tb06354.x
Membrane protein lateral interactions control Semliki Forest virus budding.
resolves10.1146/annurev.bi.56.070187.002433
INHIBITORS OF THE BIOSYNTHESIS AND PROCESSING OF N-LINKED OLIGOSACCHARIDE CHAINS
resolves10.1073/pnas.87.17.6743
Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells.
resolves10.1128/jvi.71.7.5148-5160.1997
Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription
resolves10.1016/0042-6822(89)90415-7
Monoclonal antibodies to the matrix (El) glycoprotein of mouse hepatitis virus protect mice from encephalitis
resolves10.1128/jvi.70.1.341-351.1996
Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
resolves10.1128/jvi.69.3.1984-1989.1995
Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix
resolves10.1073/pnas.83.21.8122
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
resolves10.1038/307755a0
Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides
resolves10.1093/protein/3.5.433
Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering
resolves10.1016/0092-8674(89)90873-8
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells
resolves10.1128/jvi.67.6.3489-3496.1993
Mutational analysis of the envelope gene of Moloney murine leukemia virus
resolves10.1128/jvi.63.8.3459-3465.1989
Sindbis virus ts103 has a mutation in glycoprotein E2 that leads to defective assembly of virions
resolves10.1006/viro.1994.1379
Assembly of Rubella Virus Structural Proteins into Virus-like Particles in Transfected Cells
resolves10.1016/0042-6822(81)90115-X
Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein
resolves10.1016/0168-1702(94)90070-1
Nucleotide sequence comparison of the membrane protein genes of three enterotropic strains of mouse hepatitis virus
resolves10.1128/jvi.67.5.2546-2551.1993
Site-directed mutations in the Sindbis virus E2 glycoprotein identify palmitoylation sites and affect virus budding
resolves10.1002/j.1460-2075.1994.tb06885.x
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity.
resolves10.1073/pnas.86.22.8964
Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
resolves10.1128/jvi.68.10.6523-6534.1994
Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding
resolves10.1016/S0021-9258(19)49683-X
O-glycosylation of the coronavirus M protein. Differential localization of sialyltransferases in N- and O-linked glycosylation.
resolves10.1083/jcb.124.1.55
Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step
resolves10.1074/jbc.270.15.8815
Oligomerization of a trans-Golgi/ trans-Golgi Network Retained Protein Occurs in the Golgi Complex and May Be Part of Its Retention
resolves10.1016/S0021-9258(19)36699-2
Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation.
resolves10.1038/227680a0
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
resolves10.1128/jvi.66.2.743-749.1992
Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus
resolves10.1016/0042-6822(86)90099-1
Sindbis virus mutant ts20 of complementation group E contains a lesion in glycoprotein E2
resolves10.1128/jvi.68.3.1316-1323.1994
Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses
resolves10.1128/jvi.69.6.3824-3830.1995
Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains
resolves10.1016/0042-6822(91)90034-9
Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection
resolves10.1128/jvi.68.1.328-337.1994
Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus
resolves10.1016/S0021-9258(18)68131-1
Membrane integration and intracellular transport of the coronavirus glycoprotein E1, a class III membrane glycoprotein.
resolves10.1093/protein/1.1.67
Single-stranded DNA ‘blue’ T7 promoter plasmids: a versatile tandem promoter system for cloning and protein engineering
resolves10.1016/S0092-8674(00)81072-7
Budding of Rabies Virus Particles in the Absence of the Spike Glycoprotein
resolves10.1128/jvi.70.2.873-879.1996
The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication
resolves10.1016/S0021-9258(18)55384-9
Novel purification of the catalytic domain of Golgi alpha-mannosidase II. Characterization and comparison with the intact enzyme.
resolves10.1099/0022-1317-73-10-2731
Sequence analysis of the membrane protein gene of human coronavirus OC43 and evidence for O-glycosylation
resolves10.1128/jvi.67.8.4831-4841.1993
Basis for selective incorporation of glycoproteins into the influenza virus envelope
resolves10.1002/j.1460-2075.1982.tb01346.x
Post‐translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin.
resolves10.1007/978-1-4615-9373-7_20
Glycoprotein E1 of MHV-A59: Structure of the 0-Linked Carbohydrates and Construction of Full Length Recombinant cDNA Clones
resolves10.1006/viro.1997.8480
Alphavirus Budding Is Dependent on the Interaction between the Nucleocapsid and Hydrophobic Amino Acids on the Cytoplasmic Domain of the E2 Envelope Glycoprotein
resolves10.1128/jvi.67.1.360-365.1993
Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus
resolves10.1128/jvi.58.3.884-892.1986
Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum
resolves10.1128/jvi.69.9.5475-5484.1995
Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins
resolves10.1016/S0021-9258(18)89119-0
Signal recognition particle-dependent insertion of coronavirus E1, an intracellular membrane glycoprotein.
resolves10.1128/jvi.40.2.350-357.1981
Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin
resolves10.1007/978-1-4684-5823-7_19
Expression of MHV-A59 M Glycoprotein: Effects of Deletions on Membrane Integration and Intracellular Transport
resolves10.1128/jvi.61.6.2042-2045.1987
Coronavirus E1 glycoprotein expressed from cloned cDNA localizes in the Golgi region
resolves10.1083/jcb.107.6.2163
Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor.
resolves10.1128/jvi.66.2.790-803.1992
Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity
resolves10.1128/jvi.44.3.804-812.1982
Coronavirus proteins: structure and function of the oligosaccharides of the avian infectious bronchitis virus glycoproteins
resolves10.1128/jvi.33.1.449-462.1980
Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid
resolves10.1128/jvi.66.8.4737-4747.1992
Spike protein-nucleocapsid interactions drive the budding of alphaviruses
resolves10.1083/jcb.106.5.1475
Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59.
resolves10.1002/j.1460-2075.1996.tb00553.x
Nucleocapsid‐independent assembly of coronavirus‐like particles by co‐expression of viral envelope protein genes.
resolves10.1016/0378-1119(91)90435-E
Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences
resolves10.1128/jvi.63.9.3569-3578.1989
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant
resolves10.1128/jvi.67.1.213-221.1993
Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions
resolves10.1002/j.1460-2075.1994.tb06740.x
A tyrosine‐based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding.
resolves10.1093/nar/10.20.6487
Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA
The 1 reference without a DOI — listed, not checked
no DOI — not checkedPeng D. and P. S. Masters. Unpublished data.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1128/jvi.72.8.6838-6850.1998"><img src="https://citestamp.com/citestamped/10.1128/jvi.72.8.6838-6850.1998/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1128/jvi.72.8.6838-6850.1998)